Lipid nanoparticles (LNPs) have emerged as a crucial delivery system for mRNA- based therapeutics, as demonstrated by their success in COVID-19 vaccines. However, scaling up LNP production from laboratory to industrial levels presents significant challenges. This infographic explores the key hurdles in LNP formulation development and offers potential solutions for each stage of the process.
Download now to learn about the solutions and production techniques that will be crucial for the widespread application of mRNA-based therapeutics and vaccines in the future.